Finland· FI-REL-REL60101
Virgan
A ganciclovir product containing ganciclovir, registered in Finland.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Ganciclovir
- Manufacturer
- —
- Country
- Finland (FI)
- ATC code
- QS01AD09
- ATC class
- ganciclovir
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ganciclovir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandVirgan 1,5 mg/g żel do oczuMedezin Sp. z o.o.
- SpainVIRGAN 1,5 mg/g GEL OFTALMICOLaboratoires Thea
- CzechiaVIRGANLaboratoires Thea, Clermont-Ferrand
- FranceVIRGAN 1,5 mg/g, gel ophtalmiqueTHEA
- NorwayVirganLaboratoires Théa
- BelgiumVirgan 1.5 mg/gLaboratoires Théa
- United StatesZIRGANBausch & Lomb Incorporated
- SwitzerlandVirgan 1.5 mg/g, gel ophtalmiqueTHEA Pharma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Cymevene, Ganciclovir Oresund Pharma
- Belgium · Cymevene, Virgan
- Bulgaria · Ганцикловир Ромфарм
- Czechia · Cymevene, Virgan
- Germany · Cymeven I.V., Ganciclovir Accord
- Denmark · Cymevene, Ganciclovir Oresund Pharma
- Spain · Cymevene, Ganciclovir Accord
- France · Cymevan, Ganciclovir Hikma
- United Kingdom (Northern Ireland) · Cymevene, Ganciclovir Kensington Pharma
- Greece · Gancilen, Virgan
- Croatia · Cymevene
- Hungary · Cymevene, Ganciclovir Rompharm
- Ireland · Cymevene
- Italy · Citovirax, Ganciclovir Accord
- Luxembourg · Cymevene, Virgan
- Netherlands · Cymevene, Ganciclovir Sandoz
- Norway · Cymevene, Ganciclovir Bioglan
- Poland · Cymevene, Ganciclovir Accord
- Portugal · Cymevene, Ganciclovir Accord
- Romania · Ganciclovir Rompharm, Virgan
- Sweden · Cymevene, Ganciclovir Bioglan
- Slovakia · Cymevene
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/932fa9da-b5bf-4add-a647-446df37978db GET /v1/drugs/932fa9da-b5bf-4add-a647-446df37978db?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmägeeli",
"route": null,
"ddd_unit": null,
"strength": "1.5 mg/g",
"atc_label": "ganciclovir",
"ma_number": null,
"auth_status": null,
"eu_ma_number": null,
"fimea_rel_id": "REL60101",
"authorised_at": null
}See everything about ganciclovir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.